Citeline Podcasts

1359 Episodo

1. Drug Fix: BIO CEO Departs, Makena Withdrawal Hearing Nears, New Confirmatory Evidence Sources

   Publicado: 14/10/2022
2. [3分で解説 世界のファーマ] 第6回 レカネマブ、最速ペースで承認へ

   Publicado: 14/10/2022
3. 보령의 투 트랙 R&D전략: 혁신신약과 캐시카우

   Publicado: 13/10/2022
4. What To Expect From GSCF’s World Congress 2022, With Judy Stenmark and Nicola Brink

   Publicado: 12/10/2022
5. Scrip’s Five Must-Know Things – 11 October 2022

   Publicado: 11/10/2022
6. Drug Fix: Makena Withdrawal Hearing Nears, In-Person Meetings At US FDA, User Fees Released

   Publicado: 7/10/2022
7. MagGenome Execs Talk Nanoparticle Tech, Indian Cell And Gene Therapy Opportunities

   Publicado: 7/10/2022
8. Incoming APACMed chair John Collings Outlines Regional Medtech Priorities

   Publicado: 5/10/2022
9. CEO Podcast with CanSino’s Xuefeng Yu

   Publicado: 5/10/2022
10. Scrip’s Five Must-Know Things – 3 October 2022

    Publicado: 3/10/2022
11. Drug Fix: ALS Drug Cleared, Lecanemab’s Hopeful Alzheimer’s Data, CMS’ Price Negotiation Needs

    Publicado: 30/9/2022
12. Immediate RWD Benefits For Your Early Stage Clinical Studies

    Publicado: 29/9/2022
13. Easing mRNA Manufacturing Bottlenecks – Panel Discussion Highlights Part 2

    Publicado: 29/9/2022
14. Easing mRNA Manufacturing Bottlenecks – Panel Discussion Highlights Part 1

    Publicado: 29/9/2022
15. Understand PDFUA And The Potential Impacts On Public Health

    Publicado: 29/9/2022
16. Overcoming RWD Quality and Curation Pitfalls

    Publicado: 29/9/2022
17. Leveraging RWE To Navigate The Evolving FDA Framework

    Publicado: 29/9/2022
18. Datamonitor oncology analysts discuss key abstracts presented at ESMO 2022

    Publicado: 29/9/2022
19. Chinese Language podcast on Biotech hot topics

    Publicado: 27/9/2022
20. Scrip’s Five Must-Know Things – 26 September 2022

    Publicado: 26/9/2022